<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=TFG</id>
	<title>TFG - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=TFG"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=TFG&amp;action=history"/>
	<updated>2026-04-10T20:33:35Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=TFG&amp;diff=4122&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Protein TFG (TRK-fused gene protein)  ==Publications==  {{medline-entry |title=TFG-maintaining stability of overlooked FANCD2 confers early DNA-damage res...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=TFG&amp;diff=4122&amp;oldid=prev"/>
		<updated>2021-04-29T19:01:47Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Protein TFG (TRK-fused gene protein)  ==Publications==  {{medline-entry |title=&lt;a href=&quot;/TFG&quot; title=&quot;TFG&quot;&gt;TFG&lt;/a&gt;-maintaining stability of overlooked &lt;a href=&quot;/FANCD2&quot; title=&quot;FANCD2&quot;&gt;FANCD2&lt;/a&gt; confers early DNA-damage res...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Protein TFG (TRK-fused gene protein)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=[[TFG]]-maintaining stability of overlooked [[FANCD2]] confers early DNA-damage response.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33099537&lt;br /&gt;
|abstract=Emerging Fanconi Anemia (FA) signaling in the field of cancer research annotates the extreme importance of its center player, Fanconi Anemia complementation group D2 ([[FANCD2]]) in protecting human cells from going awry. However, a previously-unrecognized form of [[FANCD2]], namely [[FANCD2]]-V2, is understudied. We report TRK-Fused Gene ([[TFG]]) is critical for roles played by [[FANCD2]]-V2 in early responses to DNA damage, but not for [[FANCD2]]-V1, the long-known form of [[FANCD2]]. [[FANCD2]]-V2 forms nuclear foci upon DNA damage, and both its focus appearance and disappearance are earlier than [[FANCD2]]-V1. The amino acid/aa 5-100 of [[TFG]] and the aa1437-1442 of [[FANCD2]]-V2 were identified to contribute to their interaction, which maintains the steady-state level of [[FANCD2]]-V2 protein. [[TFG]]Δaa5-100 or [[FANCD2]]-V2Δaa1437-1442-carrying cells could not show timely focus formation of [[FANCD2]]-V2 upon DNA damage and gained carcinogenicity over time. This study provides a previously-unknown key to unlock in-depth insights into maintaining genome stability, fostering translational studies on preventing, diagnosing and/or treating related diseases.&lt;br /&gt;
&lt;br /&gt;
|keywords=* DNA damage response&lt;br /&gt;
* FANCD2&lt;br /&gt;
* TFG&lt;br /&gt;
* aging and cancer&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655164&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>